Erlotinib Active Not Recruiting Phase 2 Trials for Carcinoma of Buccal Mucosa / Oral Squamous Cell Carcinoma / Tongue Cancers / Head and Neck Carcinoma Treatment

Active Not RecruitingTreatment2 IdentifierTitleDrugs
NCT02748707Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study
NCT01927744Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection
NCT00076310OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer